ERBB2 and osteosarcoma: Although many authors have analysed the usefulness of HER2 as a prognostic factor, Grolick et al. observed in 149 paediatric patients with osteosarcoma that its usefulness as a prognostic factor is not so clear, limiting its usefulness in osteosarcoma [37].